Send-out lab results can take days to weeks. GoDEVICE™ replaces a bench of separate instruments with one automated device: versatile sample preparation, targeted detection, NGS library preparation, and surveillance. Laboratory-grade answers at the point of need, for military and civilian use.
The cost is not only measured in dollars and equipment. It is measured in the patient waiting for an answer, the treatment delayed, and the illness that worsens in the meantime. A useful molecular answer takes four different capabilities, and today each lives on a separate instrument, in a lab, run by trained staff, with results that can take days to weeks. That does not work at the bedside, in a clinic without a lab, or in the field.
Real samples are hard. Stool, urine, blood, wastewater, environmental swabs. Prep has to handle the difficult ones, not just the clean ones.
For known pathogens and resistance genes, you need the certainty of knowing now, not after a send-out.
NGS captures the AMR SNPs and resistance mechanisms a fixed panel misses. That depth is what makes a result clinically impactful.
Larger samples across populations and environments show what is coming, not only what already arrived.
All four have to be automated, easy to use, timely, and available at the point of need. No single platform does that today. That is the gap GoDx is building for. And nothing makes it more urgent than antimicrobial resistance (AMR), the accelerating threat that every delay only deepens.
One reusable device replaces a bench of separate instruments. Each application runs on its own single-use, disposable cartridge, and GoDEVICE runs that cartridge automatically, performing versatile sample preparation, targeted multiplexed detection, library preparation for next-generation sequencing, and surveillance. Together they support pathogen and antimicrobial-resistance detection across both targeted and untargeted applications. Automated, easy to use, and built for the point of need.
Designed to remove culture and central-lab dependency from the workflow.
Proprietary target amplification enables multiplexed pathogen and AMR detection from a single prepared sample.
Built for point-of-care and point-of-need settings, not just reference labs.
The same prepared sample supports targeted detection and untargeted sequencing for discovery and surveillance.
A hardware-enabled, consumable-driven model designed for durable margins.
Consolidates prep, detection, sequencing, and surveillance across civilian care, military use, and the environment.
GoDEVICE is a portable, automated, point-of-care platform that runs an expanding menu of single-use cartridges. Field-ready and clinic-ready, it brings laboratory-grade molecular testing to the point of need.
GoDEVICE reader, shown with its field-deployable kit
In urgent care, hospitals, and decentralized clinics, GoDEVICE delivers a laboratory-grade molecular answer at the bedside, so treatment decisions happen in the same visit rather than days to weeks later.
The same device deploys forward with the warfighter. For the Department of Defense and the Defense Health Agency (DHA), GoDEVICE is built to bring molecular diagnostics to Role 1 and Role 2 care in expeditionary and austere environments where no laboratory exists. Automated and operable by non-laboratory personnel, it is designed to support force health protection, rapid infectious-disease and antimicrobial-resistance identification, and biothreat detection at the point of injury or exposure, without evacuation or send-out.
The same three steps run every application, whether you are preparing a sample, detecting a pathogen, or building a sequencing library. No lab, no technicians, no bench of instruments.
Dip the swab into the sample and insert it into the single-use cartridge.
Open the lid and slide the cartridge into GoDEVICE. Automation takes over.
GoDEVICE runs the workflow and shows the result on screen, or releases a purified sample for sequencing.
Representative current GoPREP sample types. In development, Research Use Only.
Each application runs on the shared GoDEVICE platform. All applications are in development and, where offered, are labeled for Research Use Only.
Nucleic-acid isolation and purification direct from complex samples, automating the front end of the molecular workflow.
In development
Multiplexed, point-of-care molecular detection of pathogens and their antimicrobial-resistance genes, delivering an actionable result at the point of care.
In development
Automated metagenomic next-generation sequencing library preparation for pathogen characterization, surveillance, and epidemiology.
In development
Molecular detection for wastewater and environmental samples, supporting public-health and biosecurity readiness. Dual-use across public health and defense.
In development
GoCARE is the connective data and informatics ecosystem for GoDEVICE. Every application, from GoPREP to GoDETECT, GoSEQ, and GoH2O, feeds into GoCARE, unifying results, device connectivity, and surveillance across military and civilian networks.
In development
Our first assays focus on gastrointestinal pathogens and antimicrobial resistance, building on more than a decade of diagnostic development at GoDx.
Rapid pathogen DNA identification with specific antimicrobial resistance gene detection, designed to support faster and more precise clinical decisions for gastrointestinal infection.
Research Use OnlyAn ultra-sensitive nucleic acid test kit with a 20-minute amplification and up to 8-minute lateral flow readout, supporting surveillance, epidemiology, and research applications.
Research Use OnlyBehind every result is a patient waiting for an answer and a clinician who needs to act. GoDEVICE brings molecular testing to the bedside, the clinic, and the field, so people get the right care sooner.
A diagnosis should not depend on a central lab, a courier, and a wait that stretches from days into weeks. We are building the platform that puts a molecular answer within reach of the clinic, the field, and the communities that have never had a lab at all.
Since 2017, GoDx has advanced its technology with non-dilutive federal and state support, granted intellectual property, and selective partnerships.
GoDx pairs a defensible, consolidated molecular platform with two demand engines, military and civilian, and a track record of non-dilutive support that de-risks the path forward.
We share detailed materials, including validation data, market sizing, non-dilutive funding history, and current financing terms, with qualified investors under NDA.
Contact the founders →Founded in 2017 in Madison, Wisconsin, GoDx brings together more than a decade of molecular diagnostics development with operating experience at scale. Our belief is simple. Everyone, everywhere, has the right to know their health, now.
Whether you are a health system, a federal partner, or an investor, we would like to hear from you.
